close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about major depressive disorder

Recent news which mentions major depressive disorder

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
Tickers CMPS NEWS
Tags Health Care CaaMTech Inc/ Cannabis
From Benzinga
Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
Tickers CYBN
Tags Market News CYBN neuropsychiatric treatment
From Benzinga
Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder
Tickers NEWS
Tags Cannabis Rob Conley psilocin
From Benzinga
LSD Microdosing For Depression? This Clinical Study Reveals Promising Results
Tickers NEWS
Tags Benzinga News Market News
From Benzinga
Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
Tickers CYBN
Tags Markets Psychedelics major depressive disorder
From Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
Tickers CYBN
Tags major depressive disorder Psychedelics Markets
From Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
Tickers CYBN DMTTF
Tags Benzinga Cannabis Psychedelics
From Benzinga
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
Tickers CYBN DMTTF
Tags major depressive disorder Psychedelics Markets
From Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
Tags Market News News Psychedelic/Assisted Therapies
From Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
Tickers CYBN
Tags CYBN Market News DMT Entities
From Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
Tickers MNMD
Tags General Top Stories Market News
From Benzinga
Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder
Tickers CMPS
Tags News Market News cancer
From Benzinga
DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial
Tickers DMTTF
Tags Markets Psychedelics DMTTF
From Benzinga
FSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive Disorder
Tickers HUGE
Tags Psychoactive Substances Cannabis Psychedelics
From Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
Tickers DMTTF
Tags Psychedelic/Assisted Therapies DMTTF Short/Acting Psychedelics
From Benzinga
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
Tickers CMND
Tags News Market News Penny Stocks
From Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
Tickers DMTTF
Tags Market News DMT Entities News
From Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
Tickers DMTTF
Tags Psychedelic/Assisted Therapies DMT Clinical Trial Penny Stocks
From Benzinga
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
Tickers DMTTF
Tags News Market News DMTTF
From Benzinga
FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder
Tickers EHVVF
Tags EHVVF Management FDA
From Benzinga
Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial
Tickers RLMD
Tags General premarket trading News
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Tickers MSSTF
Tags Market News News MHRA
From Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
Tickers CYBN
Tags CYBN Success Stories General
From Benzinga
New Zealand Government Grants $650K For LSD Microdosing Trials
Tickers BLRZF
Tags Benzinga Financing Frederick Pels
From Benzinga
How To Enroll In A Psychedelic Clinical Trial In 5 Easy Steps
Tags PTSD Benzinga anxiety
From Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
Tags John Hopkins University psychedelics Cannabis
From Benzinga
Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
Tickers BIIB SAGE
Tags General Market News News
From Benzinga
AbbVie's Major Depressive Disorder Candidate Shows Mixed Result In Late-Stage Trials
Tickers ABBV
Tags Briefs Trading Ideas Health Care
From Benzinga
B. Riley Sees 'Significant Potential' In This Beaten-Up Biotech Stock
Tickers SAGE SEEL
Tags Biotech Analyst Color SAGE
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today